PNC Financial Services Group’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-259
Closed -$1.28K 5080
2025
Q1
$1.28K Sell
259
-147
-36% -$467 ﹤0.01% 4470
2024
Q4
$1.19K Hold
406
﹤0.01% 4398
2024
Q3
$1.92K Hold
406
﹤0.01% 4302
2024
Q2
$1.56K Hold
406
﹤0.01% 4319
2024
Q1
$2.17K Hold
406
﹤0.01% 4177
2023
Q4
$1.73K Sell
406
-54
-12% -$166 ﹤0.01% 4220
2023
Q3
$1.8K Sell
460
-194
-30% -$1.27K ﹤0.01% 4270
2023
Q2
$6.62K Hold
654
﹤0.01% 4032
2023
Q1
$6.67K Hold
654
﹤0.01% 3951
2022
Q4
$6.13K Hold
654
﹤0.01% 3928
2022
Q3
$10K Hold
654
﹤0.01% 3782
2022
Q2
$8K Hold
654
﹤0.01% 3887
2022
Q1
$11K Buy
654
+295
+82% +$5K ﹤0.01% 3803
2021
Q4
$10K Buy
+359
New +$11.2K ﹤0.01% 3796

Other funds holding TSVT

PNC Financial Services Group's TSVT Position: Q2 2025 in Review

PNC Financial Services Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 259 shares — an estimated $1.28K sold.

PNC Financial Services Group first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $11K in Q1 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • PNC Financial Services Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 259 2seventy bio shares in Q2 2025, an estimated $1.28K.
  • PNC Financial Services Group first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • PNC Financial Services Group's 2seventy bio position peaked at $11K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.